The SPI (Figure 1) was founded in 1973 by group of 13 immunologists who felt the need to create a platform dedicated to education, interaction and state of the art discussion in fundamental and clinical immunology in Portugal. Since then, the Portuguese scientific landscape has tremendously expanded in size, quality and international competitiveness, with the SPI and its members following the same trend. Currently, we have over 400 registered members, who work in research institutes across Portugal, including Instituto de Investigação e Inovação em Saúde (I3S), Instituto de Medicina Molecular (IMM), Instituto Gulbenkian de Ciência (IGC), Champalimaud Centre for the Unknown, Instituto de Investigação em Ciências da Vida e Saúde (ICVS), Centro de Neurociências e Biologia Celular (CNC) and Institute of Biomedicine (iBiMED) and abroad, universities and in clinical care encompassing the fields of immune development and tolerance, cancer immunology, allergy, autoimmunity, vaccination, transplantation and infectious diseases.

Fundamental research in pre‐clinical models is central in understanding diseases like HIV/AIDS, malaria and tuberculosis, and autoimmunity, and progresses in parallel with the clinical research in the same fields. Since its genesis, the mission of the SPI is to promote the research in Immunology in Portugal. For this, the SPI supports and organizes scientific meetings and workshops in Portugal, and has implemented a scheme of travel awards and prizes to support young and talented researchers. Over the years, we have awarded several prominent immunologists, who have contributed to the development of SPI and the Portuguese science in general, with a honorary membership.

The SPI is committed to working in partnership with other Societies. We are affiliated with the European Federation of Immunological Societies (EFIS) (https://www.efis.org/) and the International Union of Immunological Societies (IUIS) (https://iuis.org/), and work in articulation with several Medical Portuguese Societies. Of particular relevance is the close collaboration between the SPI and the Portuguese Group of Primary Immunodeficiencies (GPIP), which was established in 2006. Our link to GPIP occurs at different levels, being the most significant the co‐organization of our annual meetings in the same occasion. The other SPI activities, including those with EFIS, are always articulated between the SPI board and a GPIP member.

In addition to our scientific mission, we are also engaged in the dissemination to the general public of the importance of the research in Immunology to Health and Disease. In this context, we have coordinated several activities at National level to celebrate the International Immunology Day since 2005. We have an active website (https://www.spimunologia.org/) and our presence in the social media is impressive, with almost 3,000 Facebook followers (https://www.facebook.com/pages/category/Organization/Sociedade-Portuguesa-de-Imunologia-1732423950345204/).

SPI（图1）是由13位免疫学家组成的小组于1973年成立的，他们认为有必要创建一个专门致力于葡萄牙基础免疫学和临床免疫学教育，互动和最新技术讨论的平台。从那时起，葡萄牙科学界的规模，质量和国际竞争力得到了极大的扩展，SPI及其成员也遵循同样的趋势。目前，我们有超过400名注册成员，他们在葡萄牙的研究机构工作，包括InvesituaçãoeInovaçãoemSaúde研究所（I3S），Medical分子研究所（IMM），Gulbenkian deCiência研究所（IGC），尚帕里莫德未知中心，美国国家科学研究所（ICVS），神经生物学中心生物圈（CNC）和生物医学研究所（iBiMED）以及国外，

临床前模型的基础研究对于理解HIV / AIDS，疟疾和结核病以及自身免疫性疾病至关重要，并且与相同领域的临床研究同步发展。自成立以来，SPI的使命是促进葡萄牙免疫学的研究。为此，SPI支持并组织了在葡萄牙的科学会议和讲习班，并实施了旅行奖励计划，以支持年轻有才华的研究人员。多年来，我们授予了几位杰出的免疫学家，这些荣誉学家为SPI和整个葡萄牙科学的发展做出了贡献。

SPI致力于与其他协会合作。我们隶属于欧洲免疫学会联合会（EFIS）（https://www.efis.org/）和国际免疫学会联合会（IUIS）（https://iuis.org/），并开展工作与几个葡萄牙医学会。特别重要的是，SPI与葡萄牙主要免疫缺陷组（GPIP）于2006年成立之间的密切合作。我们与GPIP的联系发生在不同的层面，是我们在该组织年度会议中最重要的联合组织。同一场合。SPI董事会和GPIP成员之间总是明确说明其他SPI活动，包括使用EFIS进行的活动。

除了我们的科学使命外，我们还致力于向公众传播免疫学对健康和疾病研究的重要性。在这种情况下，自2005年以来，我们已经在国家层面协调了多项活动来庆祝国际免疫学日。我们拥有一个活跃的网站（https://www.spimunologia.org/），我们在社交媒体中的影响力令人印象深刻，几乎3,000个Facebook关注者（https://www.facebook.com/pages/category/Organization/Sociedade-Portuguesa-de-Imunologia-1732423950345204/）。